close
close
bsxonair

Diamond Shruumz Edible Product Recall: Two Possible Deaths

Gillberg
Diamond Shruumz Edible Product Recall: Two Possible Deaths

The Food and Drug Administration discovered psychoactive substances in Diamond Shruumz products after consumers became ill. As of August 30, 2024, 158 cases of illness have been reported in 32 states; 63 people have been hospitalized and two potentially related deaths have been reported. In addition to vomiting and nausea, reports of serious symptoms include seizures, loss of consciousness, confusion, drowsiness, agitation, abnormal heart rhythm, and high or low blood pressure.

Diamond Shruumz is a maker of mushroom-infused chocolates and gummies. The brand touts its products as having mental health and wellness benefits. As with any product that makes vague health or wellness claims, consumers should be wary, as these claims are often illegal and made without FDA review or approval..

Diamond Shruumz Products Under Investigation

Following reports of serious adverse reactions, the FDA has launched an investigation into the outbreak. All Diamond Shruumz products have been recalled and should not be sold or purchased.

As part of their investigation, the FDA, working with partners in several states, collected and tested several Diamond Shruumz brand products. In June 2024, the results of these tests identified the psychoactive substances — 4-acetoxy-N,N-dimethyltryptamine (or 4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin) — in two products (the Diamond Shruumz Dark Chocolate Bar and the Diamond Shruumz Birthday Cake Chocolate Bar). In addition, the sampled dark chocolate bar also contained desmethoxyyangonin, dihydrokavain, and kavain.

In September, the FDA reported that ibotenic acid and muscimol were detected in a raw ingredient allegedly used in the manufacturing of some Diamond Shruumz brand products. Pregabalin, a prescription drug, was found in three samples of candy bars and five samples of infused cones.

Psilacetin is closely related to the illegal drug psilocybin and can induce hallucinations, visual illusions, and other sensory changes like psilocybin, according to the U.S. Centers for Disease Control and Prevention.

Desmethoxyyangonin, dihydrokavain, and kavain are commonly found in kava, a plant sometimes sold as a dietary supplement, and may also have psychoactive effects, causing dizziness, loss of coordination, and sedation. The FDA and the Centers for Disease Control and Prevention have raised concerns about the safety of kava, as it has been linked to liver toxicity in human and animal studies and carcinogenicity in animal studies conducted by the U.S. National Toxicology Program. The FDA has declared kava not “generally recognized as safe,” or GRAS, which makes its use in food illegal.

Testing in progress, recall in progress

Additional testing of Diamond Shruumz brand products is ongoing; some results are available as of September 5, 2024.

The FDA advises consumers to avoid these and all other Diamond Shruumz products, which are now recalled and should not be sold, purchased, or consumed.

Learn more:How Food Companies Sneak New Ingredients Past the FDA

Related Posts

Steve Buscemi attacked on the streets of New York City | National
Steve Buscemi attacked on the streets of New York City | National

Condition AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew Mexiconew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington, D.CWest VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces of AmericaForces in…